These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22253652)

  • 1. Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008.
    Dijkstra F; Jonges M; van Beek R; Donker GA; Schellevis FG; Koopmans M; van der Sande MA; Osterhaus AD; Boucher CA; Rimmelzwaan GF; Meijer A
    Open Virol J; 2011; 5():154-62. PubMed ID: 22253652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emergence of Oseltamivir-Resistant Seasonal Influenza A (H1N1) Virus in Korea During the 2008-2009 Season.
    Choi WY; Yang I; Kim S; Lee N; Kwon M; Lee JY; Kang C
    Osong Public Health Res Perspect; 2011 Dec; 2(3):178-85. PubMed ID: 24159470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.
    Nguyen JT; Hoopes JD; Le MH; Smee DF; Patick AK; Faix DJ; Blair PJ; de Jong MD; Prichard MN; Went GT
    PLoS One; 2010 Feb; 5(2):e9332. PubMed ID: 20179772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.
    Dharan NJ; Gubareva LV; Meyer JJ; Okomo-Adhiambo M; McClinton RC; Marshall SA; St George K; Epperson S; Brammer L; Klimov AI; Bresee JS; Fry AM;
    JAMA; 2009 Mar; 301(10):1034-41. PubMed ID: 19255110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.
    Bauer K; Dürrwald R; Schlegel M; Pfarr K; Topf D; Wiesener N; Dahse HM; Wutzler P; Schmidtke M
    Med Microbiol Immunol; 2012 Feb; 201(1):61-72. PubMed ID: 21688167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community spread and late season increased incidence of oseltamivir-resistant influenza A(H1N1) viruses in Norway 2016.
    Bragstad K; Hungnes O; Litleskare I; Nyrerød HC; Dorenberg DH; Hauge SH
    Influenza Other Respir Viruses; 2019 Jul; 13(4):372-381. PubMed ID: 30834715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
    Sheu TG; Deyde VM; Okomo-Adhiambo M; Garten RJ; Xu X; Bright RA; Butler EN; Wallis TR; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008.
    Pontoriero A; Baumeister E; Campos AM; Savy VL
    Rev Panam Salud Publica; 2011 Dec; 30(6):634-40. PubMed ID: 22358415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
    Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.
    Ledesma J; Vicente D; Pozo F; Cilla G; Castro SP; Fernández JS; Ruiz MP; Navarro JM; Galán JC; Fernández M; Reina J; Larrauri A; Cuevas MT; Casas I; Breña PP;
    J Clin Virol; 2011 Jul; 51(3):205-8. PubMed ID: 21592854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza viruses - antiviral therapy and resistance.
    Duwe S
    GMS Infect Dis; 2017; 5():Doc04. PubMed ID: 30671326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.
    Hurt AC; Holien JK; Parker MW; Barr IG
    Drugs; 2009; 69(18):2523-31. PubMed ID: 19943705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
    Duwe SC; Wedde M; Birkner P; Schweiger B
    Antiviral Res; 2011 Jan; 89(1):115-8. PubMed ID: 21070812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.
    Hurt AC; Holien JK; Parker M; Kelso A; Barr IG
    J Virol; 2009 Oct; 83(20):10366-73. PubMed ID: 19641000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking oseltamivir-resistance in New Zealand influenza viruses during a medicine reclassification in 2007, a resistant-virus importation in 2008 and the 2009 pandemic.
    Hall RJ; Peacey M; Ralston JC; de Joux DJ; Bocacao J; Nicol M; Ziki M; Gunn W; Wang J; Huang QS
    Western Pac Surveill Response J; 2012 Oct; 3(4):71-7. PubMed ID: 23908945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.
    Tamura D; Sugaya N; Ozawa M; Takano R; Ichikawa M; Yamazaki M; Kawakami C; Shimizu H; Uehara R; Kiso M; Kawakami E; Mitamura K; Kawaoka Y
    Clin Infect Dis; 2011 Feb; 52(4):432-7. PubMed ID: 21248368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of influenza resistance to the neuraminidase inhibitors.
    Thorlund K; Awad T; Boivin G; Thabane L
    BMC Infect Dis; 2011 May; 11():134. PubMed ID: 21592407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.